| Aravive, Inc. |
Executive Chairman, Director, 10%+ Owner |
Common Stock |
25.5M |
$23.5M |
$0.92 |
24 Oct 2022 |
Indirect |
| EYENOVIA, INC. |
Director |
Common Stock, par value $.0001 |
1.3M |
$1.77M |
$1.36 |
17 Nov 2021 |
Direct |
| EYENOVIA, INC. |
Director |
Stock Option (right to buy) |
9.65K |
$58K |
$6.01 |
17 Nov 2021 |
Direct |
| Aravive, Inc. |
Executive Chairman, Director, 10%+ Owner |
Series A Warrants (right to buy) |
8.15M |
|
|
24 Oct 2022 |
Indirect |
| Aravive, Inc. |
Executive Chairman, Director, 10%+ Owner |
Series B Warrants (right to buy) |
8.15M |
|
|
24 Oct 2022 |
Indirect |
| Aravive, Inc. |
Executive Chairman, Director, 10%+ Owner |
Warrant (right to buy) |
860K |
|
|
29 Mar 2022 |
Indirect |
| Aravive, Inc. |
Executive Chairman, Director, 10%+ Owner |
Stock Option (Right to Buy) |
97.1K |
|
|
23 Sep 2022 |
Direct |
| Aravive, Inc. |
Executive Chairman, Director, 10%+ Owner |
Pre-Funded Warrant (right to buy) |
0 |
|
|
01 Apr 2022 |
Indirect |